- $1.48m
- -$0.21m
- $6.84m
Brief: Invo Bioscience Obtains Regulatory Approval To Commercialize Invocell In Thailand
Invo Bioscience Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: INVO Bioscience Reports Q3 2021 Results
Invo Bioscience Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview
Brief: INVO Bioscience Regains Full U.S. Commercialization Rights
Brief: INVO Bioscience Announces Four Individual Poster Abstracts Discussing Benefits Of INVOcell
Brief: Invo Bioscience Inc - On October 1, Co & Certain Investors And Members Of Management Team Entered Into A Securities Purchase Agreement
Brief: Invo Bioscience Advances Invocell Commercialization Efforts With Acquisition In Canada
Invo Bioscience Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Invo Bioscience Reports Q2 2021 Financial And Operating Results
Invo Bioscience Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview
Invo Bioscience Inc Expected To Post A Loss Of 19 Cents A Share: Earnings Preview
Brief: Invo Bioscience Signs JV With Bloom Fertility
INVO Bioscience falls; names new CFO
Brief: INVO Bioscience Appoints Andrea Goren As Chief Financial Officer
Brief: INVO Bioscience Q1 Revenue Rose 165% To $684,500
Invo Bioscience Inc Reports Results For The Quarter Ended In March: Earnings Summary
Invo Bioscience Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview
Brief: INVO Bioscience Announces Appointment Of Rebecca Messina To The Board Of Directors